Injectable Drug Delivery Market Report

Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application, By Region And Segment Forecasts, 2018 - 2024

  • Published Date: Aug, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68048-GVR-8
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 65

Table of Content

Chapter 1. Methodology and Scope
                       1.1. Research methodology
                       1.2. Research scope & assumption
                       1.3. List of data sources
Chapter 2. Executive Summary
                       2.1. Injectable drug delivery market - Industry Summary and Key Buying Criteria, 2013 - 2024
Chapter 3. Injectable Drug DeliveryIndustry Outlook
                       3.1. Market segmentation
                       3.2. Market size and growth prospects, 2013 - 2024
                       3.3. Injectable drug delivery: Market dynamics
                          3.3.1. Market driver analysis
                                3.3.1.1. Escalation in demand for self- injection devices
                                3.3.1.2. Increase in the number of chronic diseases
                                3.3.1.3. Innovative technological progress
                                3.3.1.4. Development of the biologics market
                          3.3.2. Market restraint analysis
                                3.3.2.1. Needlestick injuries and infections
                                3.3.2.2. Preference over other drug delivery systems
                                3.3.2.3. Sterility of injectables
                       3.4. Injectable drug delivery market: Industry trend analysis
                       3.5. Injectable drug delivery market - PESTEL Analysis
                       3.6. Injectable drug delivery Industry analysis - Porter's Five Forces Model
                       3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
                       3.8. Key opportunities prioritized
Chapter 4. Injectable Drug Delivery Product Type Outlook
                       4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
                       4.2. By Devices
                          4.2.1. Self-injection devices
                                4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
                          4.2.2. Conventional devices
                                4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
                       4.3. By Formulations
                          4.3.1. Conventional drug delivery
                                4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
                          4.3.2. Novel drug delivery
                                4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
                       4.4. Others
                          4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook
                       5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
                       5.2. Autoimmune disorders
                          5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
                       5.3. Hormonal disorders
                          5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
                       5.4. Oncology
                          5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
                       5.5. Others
                          5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)
Chapter 6. Injectable Drug Delivery End-User Application Outlook
                       6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
                       6.2. Hospital
                          6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
                       6.3. Homecare Settings
                          6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
                       6.4. Others
                          6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 7. Injectable Drug Delivery Regional Outlook
                       7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
                       7.2. North America
                          7.2.1. The U.S.
                                7.2.1.1. The U.S. injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.2.1.2. The U.S injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.2.1.3. The U.S. injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.2.1.4. The U.S. injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                          7.2.2. Canada
                                7.2.2.1. Canada injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 - 2024 (USD Million)
                                7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                       7.3. Europe
                          7.3.1. Germany
                                7.3.1.1. Germany injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.3.1.2. Germany injectable drug delivery market by formulation, 2013 - 2024 (USD Million)
                                7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                          7.3.2. The U.K.
                                7.3.2.1. The U.K. injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.3.2.2. The U.K. injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.3.2.3. The U.K. injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.3.2.4. The U.K. injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                       7.4. Asia-Pacific
                          7.4.1. China
                                7.4.1.1. China injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.4.1.2. China injectable drug delivery market by formulation, 2013 - 2024 (USD Million)
                                7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.4.1.4. China injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                          7.4.2. India
                                7.4.2.1. India injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.4.2.2. India injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 - 2024 (USD Million)
                                7.4.2.4. India injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                       7.5. MEA
                          7.5.1. South Africa
                                7.5.1.1. South Africa injectable drug delivery market, by device, 2012 - 2024 (USD Million)
                                7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.5.1.4. South Africa injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                          7.5.2. Saudi Arabia
                                7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                       7.6. Latin America
                          7.6.1. Brazil
                                7.6.1.1. Brazil injectable drug delivery market, by device, 2013 - 2024 (USD Million)
                                7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.6.1.4. Brazil injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
                          7.6.2. Mexico
                                7.6.2.1. Mexico injectable drug delivery market, by device,2013 - 2024 (USD Million)
                                7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
                                7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
                                7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
Chapter 8. Competitive Landscape
                       8.1. Pfizer, Inc.
                          8.1.1. Company Overview
                          8.1.2. Financial Performance
                          8.1.3. Product Benchmarking
                          8.1.4. Strategic Initiatives
                       8.2. Baxter International, Inc.
                          8.2.1. Company Overview
                          8.2.2. Financial Performance
                          8.2.3. Product Benchmarking
                          8.2.4. Strategic Initiatives
                       8.3. Schott AG
                          8.3.1. Company Overview
                          8.3.2. Financial Performance
                          8.3.3. Product Benchmarking
                          8.3.4. Strategic Initiatives
                       8.4. Becton, Dickinson and Company
                          8.4.1. Company Overview
                          8.4.2. Financial Performance
                          8.4.3. Product Benchmarking
                          8.4.4. Strategic Initiatives
                       8.5. Eli Lilly and Company
                          8.5.1. Company Overview
                          8.5.2. Financial Performance
                          8.5.3. Product Benchmarking
                          8.5.4. Strategic Initiatives
                       8.6. Alkermes PLC
                          8.6.1. Company Overview
                          8.6.2. Financial Performance
                          8.6.3. Product Benchmarking
                          8.6.4. Strategic Initiatives
                       8.7. Terumo Corporation
                          8.7.1. Company Overview
                          8.7.2. Financial Performance
                          8.7.3. Product Benchmarking
                          8.7.4. Strategic Initiatives
                       8.8 Elcam Medical
                          8.8.1. Company Overview
                          8.8.2. Financial Performance
                          8.8.3. Product Benchmarking
                          8.8.4. Strategic Initiatives
                       8.9 Unilife Corporation
                          8.9.1. Company Overview
                          8.9.2. Financial Performance
                          8.9.3. Product Benchmarking
                          8.9.4. Strategic Initiatives


List of Tables

1. Injectable Drug Delivery - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
3. Injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
4. Injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
5. Injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
6. Injectable drug delivery market, by region, 2013 - 2024 (USD Million)
7. Injectable drug delivery - Key Market Driver Analysis
8. Injectable drug delivery - Key Market Restraint Analysis
9. North America Injectable drug delivery market revenue, 2013 - 2024 (USD Million)
10. U.S. injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
11. U.S. injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
12. U.S. injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
13. U.S. injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
14. Canada injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
15. Canada injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
16. Canada injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
17. Canada injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
18. Europe injectable drug delivery market revenue, 2013 - 2024 (USD Million)
19. Germany injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
20. Germany injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
21. Germany injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
22. Germany injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
23. U.K. injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
24. U.K. injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
25. U.K. injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
26. U.K. injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
27. Asia - Pacific injectable drug delivery market revenue, 2013 - 2024 (USD Million)
28. China injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
29. China injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
30. China injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
31. China injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
32. India injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
33. India injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
34. India injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
35. India injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
36. Latin America injectable drug delivery market revenue, 2013 - 2024 (USD Million)
37. Brazil injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
38. Brazil injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
39. Brazil injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
40. Brazil injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
41. Mexico injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
42. Mexico injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
43. Mexico injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
44. Mexico injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
45. MEA injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
46. South Africa injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
47. South Africa injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
48. South Africa injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
49. South Africa injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
50. Saudi Arabia injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
51. Saudi Arabiainjectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
52. Saudi Arabia injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
53. Saudi Arabia injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)


List of Figures

1. Injectable drug delivery: Market segmentation
2. Injectable drug delivery, 2013 - 2024 (USD Million)
3. Injectable drug delivery market: Industry trend analysis
4. Injectable drug delivery market: PESTEL analysis
5. Injectable drug delivery market: Porter’s analysis
6. Injectable drug delivery company market share, 2015
7. Key Opportunities Prioritized
8. Injectable drug delivery market revenue shares by device, 2016 & 2024
9. Injectable drug delivery market revenue shares by formulation, 2016 & 2024
10. Injectable drug delivery market revenue shares by therapeutic use, 2016 & 2024
11. Injectable drug delivery market revenue shares by end-user application, 2016 & 2024
12. Injectable drug delivery market revenue shares by region, 2016 & 2024

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.